Synthomer plc (LON:SYNT – Get Rating) insider Holly Van Deursen purchased 9,000 shares of Synthomer stock in a transaction on Tuesday, May 3rd. The stock was bought at an average price of GBX 308 ($3.85) per share, with a total value of £27,720 ($34,628.36).
Shares of LON SYNT opened at GBX 307 ($3.84) on Thursday. The company has a current ratio of 1.91, a quick ratio of 1.43 and a debt-to-equity ratio of 64.18. Synthomer plc has a 12 month low of GBX 241.80 ($3.02) and a 12 month high of GBX 570.50 ($7.13). The firm has a market capitalization of £1.43 billion and a PE ratio of 6.38. The firm has a fifty day simple moving average of GBX 291.83 and a two-hundred day simple moving average of GBX 373.90.
The firm also recently declared a dividend, which will be paid on Tuesday, July 5th. Investors of record on Wednesday, June 1st will be paid a GBX 21.30 ($0.27) dividend. This represents a dividend yield of 7.52%. This is a positive change from Synthomer’s previous dividend of $8.70. The ex-dividend date is Wednesday, June 1st. Synthomer’s dividend payout ratio (DPR) is presently 0.36%.
About Synthomer (Get Rating)
Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic polymers, acrylic dispersions, saturants, release coatings, and other adhesives; water-based carboxylated styrene butadiene rubber, redispersible powder, flooring adhesive, and additives for construction applications; and impregnation binders, styrene butadiene copolymers, dispersions, polymer binders, and butadiene-based binders for textiles applications.
- Limelight Networks Stock is a Speculative Turnaround Opportunity
- The Selloff In SiteOne Landscape Supply Is Overextended
- Camping World Confirms Support At Institutional Bottom
- What’s Next For Starbucks (NASDAQ: SBUX)?
- 3 Earnings Plays With Big Move Potential
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.